NeuroPace Inc SEC filings NPCE

NeuroPace Inc has 353 filings in SEC EDGAR's recent list, going back to Aug 30, 2011. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations). The company's fiscal year ends on December 31.

NeuroPace Inc SEC filings
Form Description Filed Period
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 11, 2026 Aug 11, 2026
8-K Current report
Regulation FD disclosure
Jul 28, 2026 Jul 28, 2026
8-K Current report
Shareholder vote results
Jun 8, 2026 Jun 5, 2026
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 12, 2026 Mar 31, 2026
ARS Annual report to shareholders Apr 21, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 21, 2026 —
DEF 14A Proxy statement Apr 21, 2026 Jun 5, 2026
S-8 Employee stock plan registration Mar 3, 2026 —
10-K Annual report Mar 3, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 3, 2026 Mar 3, 2026
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 12, 2025 Aug 12, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 24, 2025 Jun 20, 2025
8-K Current report
Shareholder vote results
Jun 12, 2025 Jun 6, 2025
8-K Current report
Material agreement, Agreement ended, New debt, Regulation FD disclosure
Jun 4, 2025 Jun 4, 2025
8-K Current report
Regulation FD disclosure, Other events
May 27, 2025 May 27, 2025
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 13, 2025 May 13, 2025
ARS Annual report to shareholders Apr 22, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 22, 2025 —
DEF 14A Proxy statement Apr 22, 2025 Jun 6, 2025
8-K Current report
Regulation FD disclosure
Apr 14, 2025 Apr 14, 2025
8-K Current report
Regulation FD disclosure, Other events
Apr 2, 2025 Mar 27, 2025
S-8 Employee stock plan registration Mar 4, 2025 —
10-K Annual report Mar 4, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 4, 2025 Mar 4, 2025
8-K Current report
Regulation FD disclosure, Other events
Feb 20, 2025 Feb 20, 2025
8-K Current report
Other events
Feb 18, 2025 Feb 14, 2025
424B5 Prospectus supplement Feb 18, 2025 —
8-K Current report
Material agreement
Feb 14, 2025 Feb 13, 2025
424B5 Prospectus supplement Feb 14, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Jan 28, 2025 Jan 28, 2025
8-K Current report
Regulation FD disclosure
Jan 15, 2025 Jan 15, 2025
8-K Current report
Results of operations, Officer or director change, Other events
Jan 8, 2025 Jan 6, 2025
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 13, 2024 Aug 13, 2024
8-K Current report
Shareholder vote results
Jun 10, 2024 Jun 7, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 8, 2024 May 2, 2024
ARS Annual report to shareholders Apr 22, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 22, 2024 —
DEF 14A Proxy statement Apr 22, 2024 Jun 7, 2024
S-8 Employee stock plan registration Mar 5, 2024 —
10-K Annual report Mar 5, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 5, 2024 Mar 5, 2024
8-K Current report
Officer or director change
Feb 7, 2024 Feb 1, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Jan 8, 2024 Jan 8, 2024
8-K Current report
Material agreement
Dec 4, 2023 Nov 28, 2023
10-Q Quarterly report Nov 6, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 6, 2023 Nov 6, 2023
S-8 Employee stock plan registration Aug 8, 2023 —
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Officer or director change
Jul 19, 2023 Jul 18, 2023
8-K Current report
Officer or director change
Jun 28, 2023 Jun 27, 2023
8-K Current report
Shareholder vote results
Jun 12, 2023 Jun 7, 2023
10-Q Quarterly report May 4, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 4, 2023 May 4, 2023
ARS Annual report to shareholders Apr 25, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 25, 2023 —
DEF 14A Proxy statement Apr 25, 2023 Jun 7, 2023
8-K Current report
Officer or director change
Apr 13, 2023 Apr 11, 2023
S-8 Employee stock plan registration Mar 2, 2023 —
10-K Annual report Mar 2, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 2, 2023 Mar 2, 2023
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Jan 9, 2023 Jan 4, 2023
EFFECT Filing Nov 22, 2022 —
S-3 Shelf registration Nov 8, 2022 —
10-Q Quarterly report Nov 8, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 8, 2022 Nov 8, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
8-K Current report
Material agreement, Results of operations
Aug 11, 2022 Aug 11, 2022
8-K Current report
Shareholder vote results
Jun 17, 2022 Jun 13, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 12, 2022 May 12, 2022
DEFA14A Additional proxy material Apr 22, 2022 —
DEF 14A Proxy statement Apr 22, 2022 Jun 13, 2022
S-8 Employee stock plan registration Mar 11, 2022 —
10-K Annual report Mar 10, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 10, 2022 Mar 10, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Jan 11, 2022 Jan 11, 2022
10-Q Quarterly report Nov 10, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 10, 2021 Nov 10, 2021
8-K Current report
Officer or director change
Oct 19, 2021 Oct 14, 2021
8-K Current report
Regulation FD disclosure
Sep 9, 2021 Sep 9, 2021
10-Q Quarterly report Aug 12, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 12, 2021 Aug 12, 2021
10-Q Quarterly report Jun 3, 2021 Mar 31, 2021
8-K Current report
Results of operations
Jun 3, 2021 Jun 3, 2021
8-K Current report
Bylaw or fiscal year change, Other events
Apr 26, 2021 Apr 26, 2021
S-8 Employee stock plan registration Apr 23, 2021 —
424B4 Prospectus Apr 23, 2021 —
EFFECT Filing Apr 21, 2021 —
S-1MEF Filing Apr 21, 2021 —
CORRESP Letter to the SEC Apr 21, 2021 —
CORRESP Letter to the SEC Apr 21, 2021 —
FWP Free writing prospectus Apr 21, 2021 —
POS AM Filing Apr 21, 2021 —
EFFECT Filing Apr 20, 2021 —
CERT Filing Apr 20, 2021 —
CORRESP Letter to the SEC Apr 16, 2021 —
CORRESP Letter to the SEC Apr 16, 2021 —
8-A12B Filing Apr 14, 2021 —
S-1/A Amended registration statement Apr 14, 2021 —
CORRESP Letter to the SEC Apr 9, 2021 —
UPLOAD Letter from the SEC Apr 7, 2021 —
CORRESP Letter to the SEC Apr 6, 2021 —
CORRESP Letter to the SEC Mar 24, 2021 —
S-1 Registration statement Mar 24, 2021 —
UPLOAD Letter from the SEC Feb 25, 2021 —
DRS Filing Jan 29, 2021 —
D Filing Aug 31, 2020 —
D/A Filing Aug 8, 2017 —
D Filing Jan 9, 2017 —
D Filing Jul 9, 2013 —
D Filing Aug 30, 2011 —

Showing 122 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
NPCE (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Mountain View, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1528287

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.